Beyond item level serialisation: extending traceability schemes to secondary and tertiary packagingAuthor:
Domino Printing Sciences
Whitepaper (.PDF file)
Falsified and counterfeit medicines are a chronic problem for the pharmaceutical sector, with a third of all shipments in the worst affected parts of the world estimated to contain fake medicines. To combat this, major markets and trading blocs including the EU, the USA and Latin America will enact legislation over the next few years mandating that each patient pack will have its own unique identification number. This paper will demonstrate that where serialisation is required, aggregation is a logical extension – even if not mandated – and one that delivers a range of benefits.
To download this FREE whitepaper, please complete the form below:
(all fields required)